In 2013, the Competition and Markets Authority’s (CMA) predecessor, the Competition Commission, prohibited a previous merger proposal between the hospital trusts. As a result, they were required to enter into a 10-year commitment not to merge without the CMA’s permission.
When investigating an National Health Service (NHS) hospital merger, the CMA considers the potential impact of that merger on competition between hospitals. Since the Competition Commission’s decision, there have been significant changes to policy within the NHS that have affected the role that competition plays in the provision of public healthcare services.
The CMA’s investigation in this case has confirmed that competition between NHS hospitals now plays little role in the provision of NHS services in the east Dorset area, with collaboration often viewed as a better way to meet increasing demands for care and deliver better value. In particular, the CMA found that the 2 hospital trusts have limited incentive to compete with each other, given the way that they are now funded, and so there would be no significant loss of competition in this area after the deal.
The CMA has therefore concluded that the merger does not give rise to competition concerns and should be cleared. The CMA has, in parallel, also released the hospitals from the commitment not to merge that they had given in 2013.
Full Content: Mirage News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan